Navigation Links
Thomas Jefferson University Hospital adopts new automated laboratory
Date:9/19/2011

PHILADELPHIA Thomas Jefferson University Hospital (TJUH) is advancing its laboratory testing services with new state-of-the-art equipment from Roche Diagnostics designed to help labs increase their testing capacity and deliver reliable results with greater efficiency. The high-volume, automated system allows patient blood samples to pass through processing, analysis, storage and inventory in a completely cybernated process.

The new equipment will enable the laboratory to handle the increased demand for diagnostic tests while expediting the analytic process. The capacity of individual analyzers to process blood samples will increase from 90 samples per hour to 300 per hour with the new technology.

TJUH initially expects to process approximately 3,000 to 4,000 specimens daily and provide about two to three million individual test results per year. The system will handle the vast majority of the most common laboratory tests run by the hospital.

"These state-of-the-art laboratory automation solutions are perfectly aligned with Jefferson's overall vision to constantly improve healthcare with high-quality patient care and safety," said James M. Maratea, Administrative Director for Laboratory Medicine at TJUH. "What's more, the high volumes of testing we do here make it essential that we have the highest-capacity and most efficient laboratory equipment available."

The Roche system combines three components: the Roche MODULAR PRE-ANALYTICS sample handling system, the cobas 6000 analyzer series, which includes the cobas c 501 and cobas e 601 modular chemistry and immunochemistry analyzers, and the cobas p 701 post-analytical sample storage and retrieval unit..

This is only the second installation of the Roche cobas p 701 sample storage and retrieval unit in North America, and the first in this region to adopt an automated laboratory that includes a Roche storage-and-retrieval system. Thomas Jefferson University faculty will work with the team from Roche Diagnostics to optimize this system.

The system has a mechanical "track-like" conveyer belt controlled by a central station that manages each patient sample individually. The blood sample travels along the belt, where it's labeled, centrifuged, divided into additional tubes, if necessary, and sent to analyzers. The samples are then sent to refrigeration units to be filed for possible later use.

The refrigerated post-analytical unit stores 27,000 test tubes, automatically retrieves them when additional testing is needed, and automatically discards tubes that are no longer needed. This ensures reliable and consistent results for repeat testing.

"This solution will have a significant impact on lab productivity and efficiency," said Stephen C. Peiper, M.D., Peter A. Herbut Professor and Chair of the Department of Pathology, Anatomy and Cell Biology at Thomas Jefferson University. "The new equipment will not only enhance the staff and hospital's performance even more, but also put Jefferson at the forefront of laboratory innovation."

This project is just one of several collaborations between Jefferson and Roche in the advancement of personalized healthcare for patients, including the implementation of new diagnostic tools that help physicians in the early detection, diagnosis and treatment of cancers and other diseases.


'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-6300
Thomas Jefferson University
Source:Eurekalert

Related biology news :

1. Kalyon wins Thomas Baron Award in Fluid-Particle Systems
2. American Society for Microbiology honors Thomas M. Schmidt
3. The American Society for Microbiology honors Thomas J. Walsh
4. UM College of Arts and Sciences student is awarded AACR-Thomas J. Bardos Science Education Award
5. AACR awards AACR-Thomas J. Bardos Science Education Award for Undergraduate Students
6. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
7. Jefferson Department of Surgery announces new pancreas tumor registry
8. Jefferson scientists discover a key protein regulator of inflammation and cell death
9. Jefferson researcher awarded Landenberger Foundation grant for ALS research
10. Jefferson receives $1.7 million grant to study stem cells in intervertebral discs of the spine
11. US Department of State names UCR entomologist a Jefferson Science Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology , ... recognition technologies, today announced the release of the ... which provides improved facial recognition using up to ... a single computer. The new version uses deep ... accuracy, and it utilizes a Graphing Processing Unit ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December 2016 ... extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific ... offer NAT screening for blood donors under an Investigational New Drug (IND) study protocol. ...
(Date:4/26/2017)...  Genisphere LLC, provider of the 3DNA ® ... and sponsored research agreement with the University of ... overall goal of the partnership is to study ... and formulations after in vivo administration. ... as well as inflammatory responses, demonstrating various methods ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
Breaking Biology Technology: